Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Total Current Liabilities (2023 - 2025)

Rallybio (RLYB) has disclosed Total Current Liabilities for 3 consecutive years, with $4.2 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities fell 32.35% to $4.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.2 million through Dec 2025, down 32.35% year-over-year, with the annual reading at $4.2 million for FY2025, 32.35% down from the prior year.
  • Total Current Liabilities hit $4.2 million in Q4 2025 for Rallybio, down from $4.5 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $12.2 million in Q2 2024 to a low of $3.9 million in Q1 2025.
  • Historically, Total Current Liabilities has averaged $7.3 million across 3 years, with a median of $7.4 million in 2023.
  • Biggest five-year swings in Total Current Liabilities: soared 51.01% in 2024 and later crashed 61.23% in 2025.
  • Year by year, Total Current Liabilities stood at $9.3 million in 2023, then crashed by 32.61% to $6.2 million in 2024, then crashed by 32.35% to $4.2 million in 2025.
  • Business Quant data shows Total Current Liabilities for RLYB at $4.2 million in Q4 2025, $4.5 million in Q3 2025, and $5.0 million in Q2 2025.